Single-Dose Pharmacokinetics of Milvexian in Participants with Normal Renal Function and Participants with Moderate or Severe Renal Impairment

被引：0
|
作者：
Vidya Perera
Grigor Abelian
Danshi Li
Zhaoqing Wang
Liping Zhang
Susan Lubin
Akintunde Bello
Bindu Murthy
机构：
[1] Bristol Myers Squibb,
[2] Janssen Research & Development,undefined
[3] LLC,undefined
来源：
Clinical Pharmacokinetics | 2022年 / 61卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1405 / 1416
页数：11
相关论文
共 50 条
  • [1] Single-Dose Pharmacokinetics of Milvexian in Participants with Normal Renal Function and Participants with Moderate or Severe Renal Impairment
    Perera, Vidya
    Abelian, Grigor
    Li, Danshi
    Wang, Zhaoqing
    Zhang, Liping
    Lubin, Susan
    Bello, Akintunde
    Murthy, Bindu
    [J]. CLINICAL PHARMACOKINETICS, 2022, 61 (10) : 1405 - 1416
  • [2] Single-dose Pharmacokinetics of Eluxadoline in Healthy Participants With Normal Renal Function and Participants With Renal Impairment
    Boinpally, Ramesh
    Weissman, Darren
    [J]. CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2023, 12 (02): : 132 - 140
  • [3] Single-Dose Pharmacokinetics of Milvexian in Participants with Mild or Moderate Hepatic Impairment Compared with Healthy Participants
    Vidya Perera
    Grigor Abelian
    Danshi Li
    Zhaoqing Wang
    Liping Zhang
    Susan Lubin
    Wei Chen
    Akintunde Bello
    Bindu Murthy
    [J]. Clinical Pharmacokinetics, 2022, 61 : 857 - 867
  • [4] Single-Dose Pharmacokinetics of Milvexian in Participants with Mild or Moderate Hepatic Impairment Compared with Healthy Participants
    Perera, Vidya
    Abelian, Grigor
    Li, Danshi
    Wang, Zhaoqing
    Zhang, Liping
    Lubin, Susan
    Chen, Wei
    Bello, Akintunde
    Murthy, Bindu
    [J]. CLINICAL PHARMACOKINETICS, 2022, 61 (06) : 857 - 867
  • [5] SINGLE-DOSE PHARMACOKINETICS OF BMS-986177/JNJ-70033093 (BMS-177/JNJ-3093) IN PARTICIPANTS WITH NORMAL RENAL FUNCTION AND PARTICIPANTS WITH MODERATE OR SEVERE RENAL IMPAIRMENT
    Perera, Vidya
    Abelian, Grigor
    Li, Danshi
    Wang, Zhaoqing
    Zhang, Liping
    Lubin, Susan
    Bello, Akintunde
    Murthy, Bindu
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 1839 - 1839
  • [6] Single-Dose Pharmacokinetics and Safety of Solriamfetol in Participants With Normal or Impaired Renal Function and With End-Stage Renal Disease Requiring Hemodialysis
    Zomorodi, Katie
    Chen, Dan
    Lee, Lawrence
    Lasseter, Kenneth
    Marbury, Thomas
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 59 (08): : 1120 - 1129
  • [7] Pharmacokinetics of single-dose morinidazole in patients with severe renal impairment
    Zhang, Hao
    Huang, Lu
    Huang, Yuan-yuan
    Yi, Bin
    Pei, Qi
    Tan, Hong-yi
    Huang, Jie
    Liu, Ji-shi
    Yuan, Hong
    Yang, Guo-ping
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2014, 52 (02) : 159 - 165
  • [8] Pharmacokinetics and Safety of Single-dose Atogepant in Participants with Hepatic Impairment
    Boinpally, R.
    Jakate, A.
    Butler, M.
    Borbridge, L.
    Periclou, A.
    [J]. HEADACHE, 2020, 60 : 45 - 46
  • [9] Pharmacokinetics, Safety, and Tolerability of Single-Dose Elbasvir in Participants with Hepatic Impairment
    Marshall, William L.
    Feng, Hwa-Ping
    Wenning, Larissa
    Garrett, Graigory
    Huang, Xiaobi
    Liu, Fang
    Panebianco, Deborah
    Caro, Luzelena
    Fandozzi, Christine
    Lasseter, Kenneth C.
    Preston, Richard A.
    Marbury, Thomas
    Butterton, Joan R.
    Iwamoto, Marian
    Yeh, Wendy W.
    [J]. EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2018, 43 (03) : 321 - 329
  • [10] Pharmacokinetics, Safety, and Tolerability of Single-Dose Elbasvir in Participants with Hepatic Impairment
    William L. Marshall
    Hwa-Ping Feng
    Larissa Wenning
    Graigory Garrett
    Xiaobi Huang
    Fang Liu
    Deborah Panebianco
    Luzelena Caro
    Christine Fandozzi
    Kenneth C. Lasseter
    Richard A. Preston
    Thomas Marbury
    Joan R. Butterton
    Marian Iwamoto
    Wendy W. Yeh
    [J]. European Journal of Drug Metabolism and Pharmacokinetics, 2018, 43 : 321 - 329
12345